Cladribine Tablets Reduce Relapses in Relapsing-Remitting Multiple Sclerosis

Reserachers evaluated data from the CLARITY study to test the efficacy of cladribine tablets on frequency and severity of relapses for patients with multiple sclerosis.

Source link

Related posts

Paraneoplastic neuromyelitis optica associated with fever of unknown origin as an early manifestation: A case report.


Antidepressants could stave off dementia


Author response: The intolerable burden


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy